Together for Short Lives
Call the Helpline 0808 8088 100

Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy

Publication year
2008
Author(s)
Cartier, N.; Aubourg, P.
Pages
471-8
Volume
10
Number
5

Hurler syndrome, metachromatic leukodystrophy, globoid-cell leukodystrophy (Krabbe’s disease) and X-linked adrenoleukodystrophy are inherited diseases of the CNS that can be cured or arrested by allogeneic hematopoietic stem-cell transplantation (HSCT). Despite significant progress in medical procedures and the availability of banked umbilical cord blood, HSCT is still associated with significant risks of graft failure or GVHD that can lead to death. Transplantation of autologous hematopoietic stem cells genetically modified to express the missing protein may circumvent the majority of the problems associated with allogeneic HSCT. Promising in concept, these strategies are now at a stage to be tested in phase I/II clinical trials to assess safety and potential efficacy.

Research abstracts